Perrigo (PRGO) Acquisitions (2013 - 2025)

Perrigo (PRGO) posted quarterly Acquisitions of -$1.5 million for Q1 2025, up 88.72% quarter-over-quarter from -$13.3 million in Q4 2024.

Perrigo (PRGO) Acquisitions (2013 - 2025) Analysis & Trends

Perrigo (PRGO) has reported Acquisitions for 11 consecutive years, with -$1.5 million the latest figure, recorded in Q1 2025.

In Q1 2025, Acquisitions changed N/A year-over-year to -$1.5 million; the TTM figure through Dec 2025 stood at -$1.5 million (up 88.72% YoY), while the FY2025 annual figure was -$1.5 million, up 88.72% from the prior year.
Acquisitions rose to -$1.5 million in Q1 2025 per PRGO's latest filing, from -$13.3 million in the prior quarter.
Across five years, Acquisitions topped out at -$1.5 million in Q1 2025 and bottomed at -$1.9 billion in Q4 2022.
Historically, Acquisitions has averaged -$496.7 million across 4 years, with a median of -$41.9 million in 2021.
Annual changes were most pronounced in 2021 — Acquisitions sank 212.96% — and 2022, when it sank 2593.2%.
Perrigo's Acquisitions stood at -$70.6 million in 2021, then tumbled by 2593.2% to -$1.9 billion in 2022, then soared by 99.3% to -$13.3 million in 2024, then jumped by 88.72% to -$1.5 million in 2025.
Business Quant data shows PRGO's Acquisitions at -$1.5 million in Q1 2025, -$13.3 million in Q4 2024, and -$1.9 billion in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.07 Bn	39.42 Bn	2.15 Bn	-
3	Zoetis	31.53 Bn	29.85 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn	-
5	United Therapeutics	22.13 Bn	19.47 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	-
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-	-
10	Perrigo	1.94 Bn	1.54 Bn	313.90 Mn	-

Download Data